Background {#Sec1}
==========

Malaria is a febrile illness infecting humans and primarily caused by parasites transmitted to humans by female mosquitoes belonging to genus *Anopheles* \[[@CR1]\]. This parasite belongs to the genus *Plasmodium*, of which five species (*P*. *vivax*, *P*. *malariae*, *P*. *ovale*, *P*. *knowlesi*, and *P*. *falciparum*) are responsible for human malaria. Malaria represents of one the most life-threatening infectious diseases in humans. According to the World Health Organization (WHO), 95% of malaria cases are caused by *P. falciparum*; 228 million cases of malaria are recorded with nearly 435,000 deaths linked to this disease worldwide in 2018 \[[@CR2]\]. The sub-Saharan Africa (SSA) region is the most affected by malaria with 93% and 94% of all disease cases and deaths occurred worldwide \[[@CR2]\].

The endemicity of this disease in SSA has a negative impact on the professional world \[[@CR3], [@CR4]\] as it slows down business productivity \[[@CR4]\] and consequently economic growth in several countries \[[@CR5]\]. In SSA countries, many control strategies actions, such as the use of long-lasting insecticide-treated mosquito net campaigns \[[@CR6]\], indoor residual spraying and sanitation campaigns, have been taken by many countries government and non-governmental organizations to fight against malaria \[[@CR7]--[@CR10]\]. Unfortunately, these measures were taken mainly in the community \[[@CR6]\] as well as a small part in the professional environment. However, the diagnostic component has not yet been clearly addressed by governments. To assist government intervention, private companies must play a big role in the fight against malaria through funding and also execute programs for the implementation of sustainable strategies.

In order to reduce or eradicate malaria in the workplace, several strategies have been put in place, namely, sensitization and distribution of insecticide-treated nets (ITNs) \[[@CR11]\], the creation of health centers/infirmary to promptly diagnose infection cases \[[@CR12], [@CR13]\], and care management. Reliable diagnosis will help to build improved targeted prevention programs \[[@CR12]\]. Several diagnostic methods have been developed such as quantitative buffy coat, immunochromatographic rapid diagnostic tests (RDTs), and serological tests \[[@CR14]\]. Some companies have adopted the use of conventional microscopy or RDTs in testing for malaria in suspected patients. Unfortunately, these techniques have some drawbacks. For example, light microscopy (LM) is time-consuming and requires the use of quality reagents and skilled microscopist. On the other hand, the immunochromatographic RDTs (1) cannot make a distinction between acute and past infection and (2) can elicit false negative due to bad handling, prozone effect, and recently to deletions in the histidine-rich protein II gene especially for RDTs targeting PfHRP2 protein of *P. falciparum* \[[@CR15]\].

In view of this, there is need for new diagnostic methods that can overcome the abovementioned limitations of LM and immunochromatographic RDTs. Fluorescence-based methods may be used as an alternative especially that based on the use of 4′,6-diamidino-2-phenylindole (DAPI) as fluorochrome \[[@CR16]\]. This technique relies on the staining of plasmodial genomic material with DAPI followed by ultraviolet excitation of this fluorochrome and finally, microscopic detection of malaria parasites using a microscope called Cyscope® \[[@CR17]\]. Malaria parasites are identified as luminescent small spots as compared to white blood cells (WBC) that appear bigger (Fig. [1](#Fig1){ref-type="fig"}). The Cyscope® is already using by many researchers and had been evaluated in community field for diagnosis of malaria and other diseases such as urinary schistosomiasis and gastrointestinal infections \[[@CR13], [@CR18]--[@CR20]\]. Based on the peculiarity of this diagnostic technique, this study was conducted to investigate the performances of Cyscope® fluorescence microscope (FM) in comparison with light microscopy (LM) at the workplace. The aim was to determine if this diagnostic tool can be valuably used at the workplace as an integrative part of health strategies developed by companies to fight against malaria. Fig. 1**a**--**c** Cyscope® microscope (Partec-Sysmex, Japan). **d** Positive malaria slides under observation with CyScope®. Bigger spots correspond to WBC and the smaller spots to malaria parasites (Photographs are provided by the authors)

Materials and methods {#Sec2}
=====================

Study sites and population {#Sec3}
--------------------------

The present study is part of a larger study on malaria carried out in some companies in the town of Douala, Littoral Region, Cameroon. The conditions and characteristics of the study site have been described elsewhere \[[@CR21]\]. Briefly, Douala represents the economic capital with 35.1% of companies of Cameroon. The climate of Douala is warm and humid with a constant temperature of about 26 °C and very heavy rainfall, especially between June and October which facilitates malaria transmission. These two reasons have guided the choice of these sites \[[@CR21]\].

In order to preserve their notoriety, activity-guided codes were assigned to the companies involved in this study, namely, CON and BPT. These companies are based in third district of Douala. Company CON is a dealer of vehicles of several foreign brands while company BPT is focused on buildings and public works. The companies CON and BPT are endowed with an infirmary which allows the employees to manage their health problems including malaria. In addition, the companies have implemented strategies to fight against malaria as distribution of ITNs and education campaigns on malaria.

Study design {#Sec4}
------------

This cross-sectional study was conducted on 21 and 22 March 2017 in two companies of the town of Douala. Prior to the field investigation, all administrative and ethical authorizations were issued by companies investigated and ethical committee of the University of Douala. After obtaining approval from the companies, members of communication cell of each company were approached in order to inform employees on the objectives and dates of the study. Employees were recruited with respect to their recent history of antimalarial drug use. Persons who have received quinine, artemisinin derivatives within the last 7 days, 4-aminoquinolines within the last 14 days, pyrimethamine and/or sulfonamides within the last 28 days, or mefloquine within the last 56 days were excluded from the study. Any employee who was working in any of these two companies and who signed informed written consent was included in the study.

The sample size of study population was calculated with regard to the following formula used for diagnostic studies as defined by Hajian-Tilaki et al. \[[@CR22]\]. $$\documentclass[12pt]{minimal}
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where *P*~0~ denotes the pre-determined value of sensitivity of new diagnostic test (95%); *P*~1~ is the value of sensitivity under alternative hypothesis observe in the field (98.3% ) \[[@CR23]\]. The parameters Z~α/2~ and Z~β~ denote the percentiles of standard normal distribution and α, β are the probability of type I and type II errors respectively. In this study *α* = 0.05, Z~α/2~ is equal 1.96 and *Z*~β~ is equal 0.84, and d = accepted margin of error (5%). The estimated minimum sample size was estimated *n* = 199.7. A total of 442 employees were enrolled in this study.

Sample and data collection {#Sec5}
--------------------------

Before blood sample collection from the targeted employees, they were debriefed verbally and encouraged to sign an informed consent form before sample collection using a pre-tested structured questionnaire. Demographic data such as the name, gender, age, and auxiliary temperature of each employee were recorded before blood collection for detection of malaria parasites. The diagnosis of malaria was confirmed by both LM and FM.

Laboratory detection {#Sec6}
--------------------

### Fluorescence microscopy {#Sec7}

FM was performed according to the manufacturer's recommendation (Partec-Sysmex, Japan). Briefly, middle finger of each employee was cleaned with a cotton swab soaked in ethanol at 70°, and blood was drawn using a lancet. The first drop of blood was discarded, and the second (\~ 10 μL) was deposited on a fluorochrome dried, the DAPI, on the center of the slide. The preparation is covered with a coverslip and incubated in a sunlight-free area at room temperature for 1 min. Parasites were observed at the × 40 objective of Cyscope®, and the results were interpreted as described previously \[[@CR17]\].

### Light microscopy {#Sec8}

This detection technique was performed as described by Cheesbrough \[[@CR24]\]. Two blood drops were deposited on a glass slide to make thick and thin blood smears, respectively. Thin smear was used to identify different malaria species while thick smear was used to determine parasitemia. Thin smears were fixed using absolute methanol, stained with 10% Giemsa, and then allowed to dry for 30 min. Blood drop used to make thick smear is stirred on circular motion with the corner of another glass slide and left dry for 15 min without fixative. Thick smear is then stained with 10% Giemsa, washed with buffered water , and allowed to dry for 30 min. The slides were read under immersion oil at × 100 objective lens. Parasites were counted against 200 leucocytes by assuming a mean count of 8000 leucocytes/μL for each individual \[[@CR25]\]. Different developmental stages of *Plasmodium* were identified. Slides were read by three skilled microscopists, and the agreement between at least two of them was considered as final result of parasitological reading. Parasitemia was categorized as low (\< 500 parasite/μL of blood), moderate (501--5000 parasites/μL of blood), and high (\> 5000 parasites/μL of blood) according to Allen et al. \[[@CR26]\]. Asexual parasites and gametocytes were counted against 200--500 leucocytes and converted to number of parasites per volume assuming 8000 leucocytes/μL of blood \[[@CR25]\].

Operational definitions {#Sec9}
-----------------------

▪ Asymptomatic malaria defines the case of a patient diagnosed with the test but having an axillary temperature \< 37.5 °C \[[@CR17]\].▪ Symptomatic malaria defines the case of a patient diagnosed as having a positive test, but having an axillary temperature ≥ 37.5 °C \[[@CR17]\].▪ True positive (TP) patients are diagnosed and positive in both tests. These are participants who have the disease and have the test is positive \[[@CR13], [@CR27]\].▪ False positive (FP) patients are diagnosed and positive by FM but negative by ordinary microscopy. These are participants who do not have the disease but are test positive \[[@CR13], [@CR27]\].▪ False negative (FN) participants are diagnosed and negative on FM but positive on ordinary microscopy. These are participants who have the disease but the test is negative \[[@CR13], [@CR27]\].▪ True negative (TN) participants are the participants who are diagnosed and negative for both tests \[[@CR13], [@CR27]\].▪ Sensitivity (Se) is the ability of the test to correctly identify those who have the disease: Se = TP/(TP + FN) \[[@CR28]\].▪ Specificity (Sp) is the ability of the test to correctly identify those who do not have the disease: Sp = TN/(TN + FP) \[[@CR28]\].▪ Positive predictive value (PPV) is the probability that a disease is present when the test is positive: PPV = TP/(TP + FP) \[[@CR29]\].▪ Negative predictive value (NPV) is the probability that a disease is absent when the test is negative: NPV = TN/(TN + FN) \[[@CR30]\].▪ Positive likelihood ratio (PLR) is the ratio between the probability of having a positive test when the person is sick and the probability of having a positive test when the person is not sick: PLR = Se/(1-Sp) \[[@CR28], [@CR31]\].▪ Negative likelihood ratio (NLR) is the ratio between the probability of having a negative test when the person is sick and the probability of having a negative test when the person is not sick: NRL = (1-Se)/Sp \[[@CR32]\].▪ Accuracy is the probability that a patient have been correctly classified according to the result of the test: accuracy = (TP + TN)/(TP + TN + FP + FN) \[[@CR33]\].▪ Reliability of a diagnostic test depends on the accuracy and reproducibility of the test results: reliability = \[(TP × TN)−(FP × FN)\]/(TP + FN) × (TN + FP) \[[@CR30]\].▪ Kappa (k) values expressed the agreement beyond chance and were calculated with a 95% confidence interval. A kappa value of 0.21--0.60, 0.61--0.80, and \> 0.80 was considered as moderate, good, and almost perfect agreement beyond chance, respectively \[[@CR34]\].

Statistical analysis {#Sec10}
--------------------

All data obtained were subjected to analysis by using the Statistical Package for Social Science (SPSS) software version 16 (SPSS Inc., Chicago, IL, USA). McNemar's chi-square test was used to compare the prevalence of malaria infection between LM and FM. Pearson's chi-square and non-parametric Mann-Whitney tests were used to compare unpaired proportions and mean values of parasitemia, respectively. Parasitemia was log~10~-transformed before performing statistical analysis. Statistical significance was set at *p* value \< 0.05.

Results {#Sec11}
=======

Demographic characteristics of study participants {#Sec12}
-------------------------------------------------

Table [1](#Tab1){ref-type="table"} summarizes the sociodemographic characteristics of the study population. Out of the 442 employees recruited in the study, 83.9% were male, and nearly half of the participants were aged between 19 and 35 years old (47.5%) and had completed secondary level of education (47.6%). Most employees were belonging to the worker professional category (59%) and living in the third district of Douala (63.6%). More than 87.3% of the employees diagnosed were afebrile. Table 1Baseline characteristics of study populationParametersFrequencies (%) or mean ± SD**Companies** CON279 (36.9) BPT163 (63.1)**Age**  \[19--36\[210 (47.5)  \[36--60\[200 (45.2) ≥ 6032 (7.2) Mean age (SD)37.8 (9.7)**Gender** Male:female ratio3.86:1**Fever** (axillary temperature ≥ 37.5 °C) Yes56 (12.7) No386 (87.3)**Level of education** Primary46 (10.4) Secondary158 (35.7) University128 (29.0) Missing data110 (24.9)**Professional category** Workers261 (59.0) Managers71 (16.1) Missing data110 (24.9)**Subdivision** Douala 120 (4.5) Douala 217 (3.8) Douala 3208 (47.1) Douala 415 (3.4) Douala 566 (14.9) Out of Douala1 (0.2) Missing data115 (26)*SD* Standard deviation

Prevalence of malaria {#Sec13}
---------------------

The prevalence of malaria was 39.2% (173/441) and 17% (75/441) using FM and LM, respectively, and the difference was statistically significant between both the methods (McNemar test, *p* \< 0.01). *Plasmodium falciparum* and *P. vivax* were the two species identified in this study (Table [2](#Tab2){ref-type="table"}). All cases were mono-infection with either of the *Plasmodium* species identified; thus, the prevalence of *P. falciparum* and *P. vivax* among infection cases was 96% and 4%, respectively. In terms of developmental stages, 68% of employees diagnosed with malaria using LM carried gametocytes while trophozoites and schizonts were found in 45.3% and 1.3% of them, respectively. The geometric mean parasite density (GMPD) was 1850 parasites per μL of blood (ranges between 1600 and 40,000) while most of the employees (60.8%) had moderate parasitemia. Regarding the three *P. vivax* cases recorded, two of them had moderate parasitemia while the remaining case had low parasitemia. Table 2Malariometric variables using light microscopyFactors***N*** (%)**Species***P. falciparum*72 (96)*P. vivax*3 (4.0)**Stages** Gametocytes51 (68.0) Trophozoites34 (45.3) Schizonts1 (1.3)**Parasitemia (parasites/μL)** Low (1--500)26 (35.1) Moderate (501--5000)45 (60.8) High (\> 5000)3 (4.1) )

Diagnostic performances of FM {#Sec14}
-----------------------------

Based on the results shown in Table [3](#Tab3){ref-type="table"}, the diagnostic performances of FM were as follows: Se = 84%, Sp = 69.95%, PPV = 63.58%, NPV = 95.5%, accuracy = 89.36%, reliability = 53.95%, and kappa = 0.43, respectively. FM was not able to detect 12 cases which were positive by LM, and mean parasitemia for these cases was 170 parasites/μL. Table 3Cyscope® FM results compared to LM results with respect to clinical statusCyscope® FMAllFebrileAfebrilePositiveNegativeTotalPositiveNegativeTotalPositiveNegativeTotal**LM**Positive63127543759968Negative11025636617324993224317**Total173268441**^a^**213556152233385***FM* Fluorescence microscopy, *LM* Light microscopyData are presented as frequency^a^Parasitological result was missing for one individual

Despite the fact that the sensitivity of Cyscope® FM was lower in febrile patients as compared to their afebrile counterparts, no statistically significant difference was observed between the two groups (57.14% vs 86.16%, *p* value = 0.74) (Table [4](#Tab4){ref-type="table"}). It should be noted that mean parasitemia was slightly higher in afebrile patients (1947 parasites/μL) compared to that of febrile patients (1029 parasites/μL). Table 4Diagnostic performances of Cyscope® FM with regard to clinical statusParametersAll (***n*** = 441)Febrile (***n*** = 56)Afebrile (***n*** = 385)***P*** valueValue95% CIValue95% CIValue95% CISe (%)84.0074.08--90.6057.1425.04--84.1886.7676.71--92.870.74Sp (%)69.9565.07--74.4265.351.32--77.0870.6665.42--75.400.92PPV (%)63.5856.19--70.3819.057.67--40.038.8131.44--46.750.3NPV (%)95.5588.31--94.7291.4377.62--97.0496.1392.83--97.961PLR2.8--1.65NA2.95NA--NLR0.23--NANANANA--Accuracy (%)89.3683.34--90.2110.0851.2--75.8579.2768.89--77.670.63Reliability (%)53.95--22.45--57.43----Kappa0.45-----------*CI* Confidence interval, *FM* Fluorescence microscopy, *Se* Sensitivity, *Sp* Specificity, *PPV* Positive predictive value, *NPV* Negative predictive value, *PLR* Positive likelihood ratio, *NLR* Negative likelihood ratio, *NA* Not applicable. Pearson's chi-square test was used to make comparisons. Significance was set at *p* value \< 0.05

Besides, sensitivity of Cyscope® microscope increased as a function of parasitemia with values ranging from 76.92% (95% CI 57.95--88.96%) in patients with parasitemia comprised between 1 and 500 parasites/μL to 91.11% (95% CI 79.27--96.49%) in patients with parasitemia comprised between 501 and 5000 parasites/μL. The difference between sensitivity values was not statistically significant (*χ*^2^ = 1.69, df = 1, *p* value = 0.19). It was not possible to compute the sensitivity for group of patients with parasitemia above 5000 parasites/μL because of small sample size for this group (*n* = 3).

Discussion {#Sec15}
==========

The present study aimed at evaluating the diagnostic performances of Cyscope® FM in the detection of carriers of malaria parasites. The overall prevalence of malaria was 39.2% using FM and 17% using LM. The two malaria species involved in infection cases were *P. falciparum* and *P. vivax*. Many studies reported the circulation of *P. vivax* and its involvement in malaria burden in Cameroon \[[@CR32], [@CR35], [@CR36]\].

In our study, we found 96% of malaria cases were due to *P. falciparum*, and this is line with the finding of Sandeu et al. who recorded the predominance of this species in a study conducted in Center and Southern regions of Cameroon \[[@CR37], [@CR38]\] and about 4.4 % greater than that which was reported by Kimbi et al. \[[@CR13]\] in the southwest part of Cameroon \[[@CR13]\]. *P. falciparum* is the cause of almost all malaria infections observed in Africa \[[@CR2]\] and in particular, in Cameroon \[[@CR39]\].

Most of infections cases were due to *P. falciparum*, and this is consistent with previous studies carried out in the Southern part \[[@CR13], [@CR18], [@CR29]\] and in the Littoral region of Cameroon \[[@CR17]\]. Briefly abovementioned, *P. vivax* was reported in the present study. Many previous molecular studies revealed the presence of this species in the country \[[@CR32], [@CR40]\]. This species is being considered minor in SSA due to its high level of individual deficient with red blood cell Duffy antigen, a receptor requested for the invasion of RBC by the parasite \[[@CR41]\]. This fact is increasingly refuted as many studies reported *P. vivax* infection cases among Duffy-negative individuals in SSA especially in Cameroon \[[@CR40], [@CR42]\]. This suggests that either the partial role of Duffy antigen as invasion-aimed receptor or possible adaption of the parasite. Besides, the control of *P. vivax* is a veritable challenge due among others: (i) the production of dormant development stages (hypnozoites) for which all currently available antimalarial drugs, with the exception of primaquine, are inefficient, (ii) diagnosis-related problems as it may confuse with *P. ovale*, (iii) infection cases at low parasitemia that are generally revealed using molecular methods, and (iv) difficulty to cultivate this parasite \[[@CR43]\]. In an attempt in eliminating malaria, it is of utmost importance to pay attention on non-falciparum species in fight strategies especially in SSA.

Concerning the performances of FM, we found a sensitivity value of 84% similar with the result of several other studies which also recorded values close to 95% in Southern Cameroon \[[@CR13], [@CR18], [@CR29]\], in Uganda \[[@CR44]\], Sudan \[[@CR23]\], Ghana \[[@CR34]\], and Ethiopia \[[@CR45]\]. The sensitivity that we found was little less than those reported by Ndamukong-Nyanga et al. (87.6%) \[[@CR18]\] and Kimbi et al. (91.3%) \[[@CR13]\]. This can be explained by the difference of the study population and the area of study. Their study population was children, and the study took place in one of the rural zone in Southwest Cameroon while the present study was conducted among adults residing in an urban region. In general, malaria burden (i.e., prevalence and level of parasitemia) is higher in children and rural areas as compared to adults and urban areas, respectively \[[@CR2], [@CR46], [@CR47]\]. These factors can influence the performances of malaria diagnostic tests \[[@CR17]\]. The Cyscope® microscope gave 12 FN results which were positive with LM, and this could be due to low parasitemia. Indeed, the mean parasitemia for these 12 cases was 170 parasites/μL, and this is consistent with the finding of Sousa-Figueiredo and co-workers reported that the detection of positive cases using Cyscope® microscope was easier when parasitemia is above 400 parasites \[[@CR44]\].

The specificity that we found (69.9%) was less than that which was found by Hassan et al. (98.3%) \[[@CR23]\]. This difference could be related to difference in study population as can be explained by their study population which was all patients with fever reporting to the malaria Centre (Sinnar Hospital). Many researchers have shown the significant association between malaria and infection fever \[[@CR48], [@CR49]\]. Several false positives found can be the artifact such as dust \[[@CR44]\] or the bacterial \[[@CR50], [@CR51]\] and schistosome DNA which have been seen to be confused with plasmodial DNA \[[@CR34], [@CR44]\]. In some cases, false positives can result in overuse of antimalarial drugs, thus unnecessarily exposing individuals to toxicity of antimalarial drugs and at larger level to increase in risk for appearance and spread of drug resistance \[[@CR44]\].

LM, a standard technique, has the advantage that can discriminate and quantify plasmodial species \[[@CR23]\]. However, it has some drawbacks limiting its optimal utilization in African settings. These include mainly the need for skilled microscopist, good quality reagents and microscope, and electricity which is often lacking in resource-limited and difficult-to-reach areas \[[@CR17], [@CR21], [@CR45], [@CR52]\]. In addition, the method is particularly time consuming which is not allow for prompt management of malaria cases. Finally, washing steps increase the losses of malaria parasites and thus reduce the chances to detect parasites especially in low parasitemia infections. In such situations, the implementation of LM is particularly challenging. These limitations of LM are transposable in company milieu where infirmary and health point-of-care in companies face the same difficulties to diagnose malaria. In contrast, Cyscope® may overcome the limitations of LM as the technique is rapid (\~ 2 min/test), cheap, request little training, has no washing steps, and can be used in the absence of electricity as the Cyscope® is endowed with an in-built 6-h batteries. These abovementioned characteristics have been convincing its utilization by more and more authors in different contexts in Cameroon such as active case detection of malaria cases in community especially in remote areas where electricity is often lacking and passive case in health facilities \[[@CR13], [@CR17], [@CR18]\]. In addition, a study showed that Cyscope® FM is cost-effective for community diagnosis of malaria as compared to immunochromatographic RDTs, quantitative buffy coat microscopy, and LM, suggesting a more important utility of Cyscope® FM in malaria endemic areas especially in SSA countries \[[@CR53]\].

Sensitivity of Cyscope® has increased as a function of parasitemia with values ranging from 71 (1--500 parasites/μL) to 91% (501--5000 parasites/μL), and this is consistent with previous studies \[[@CR29], [@CR54]\]. The higher the parasitemia, the more the chances the test of interest gives a positive result.

Surprisingly, sensitivity of Cyscope® microscope was better in afebrile individuals as compared to their febrile counterparts, although no statistically significant difference was found. This can be explained by differences in level of parasitemia in these two groups as level of parasitemia was on average higher in afebrile individuals. In addition, it should be noted that fever is not a pathognomonic sign of malaria infection as infections caused by virus and bacteria can also elicit fever. Studies outlined that a large proportion of febrile illness episodes were caused by urinary tract infection bacteria mainly *Escherichia coli*, *Staphylococcus aureus*, and *Streptococcus pneumoniae* \[[@CR55], [@CR56]\]. In Cameroon, Achonduh-Atijegbe and colleagues reported that *Toxoplasma gondii* and *Salmonella typhii* were involved in fever cases among children \[[@CR57]\]. Thus, some fever cases reported in the present study were of non-malarial origin, and this aspect has not been addressed. It would be interesting to address this aspect in future investigations.

The study has some limitations. First, polymerase chain reaction-based molecular method was not used as gold standard. Although this method is more sensitive than LM \[[@CR23]\], it is not affordable for most health companies in malaria endemic areas, and their utilization is limited to research needs. Thus, the comparison of Cyscope® with LM is more logical and practical. Secondly, this study was conducted in a few companies, and the findings cannot be generalizable to all companies of Cameroon.

Conclusion {#Sec16}
==========

The Cyscope® microscope has appreciable sensitive and specificity compared to the LM at the workplace. In this environment of workplace, operational characteristics of the Cyscope® will make it more adaptable at workplace than LM. The Cyscope® can therefore be recommended to all types of companies for a prompt and better diagnosis of malaria.
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